Most Popular
Sponsored
Spirit Airlines grounds all flights, ceasing operations. Investors face total loss as valuation hits zero.
Cigna beats Q1 revenue & EPS estimates, raises guidance. Specialty pharmacy & AI drive growth. Valuation looks attractive.
Oil nears $120/bbl on supply shock; could hit $150+. CVX & COP poised to profit.
LECO beats Q1 revenue & EPS estimates on strong pricing. Sees modest volume growth ahead, but risks from inflation & global conflict.
Boeing's MQ-25 drone nears flight tests, promising a 33% carrier attack boost. Program cost: $15.9B.
ResMed beats revenue/EPS, but market shrugs. Margin expansion seen, but costs loom. Buy RMD?
Iren & Nebius ink $B+ AI data center deals. Nebius leads in new contracts, Iren boasts larger future capacity & ARR potential.
Sponsored
Must Read
